181 related articles for article (PubMed ID: 8643100)
1. The effect of the removal of sialic acid, galactose and total carbohydrate on the functional activity of Campath-1H.
Boyd PN; Lines AC; Patel AK
Mol Immunol; 1995 Dec; 32(17-18):1311-8. PubMed ID: 8643100
[TBL] [Abstract][Full Text] [Related]
2. Characterization of monoclonal antibody glycosylation: comparison of expression systems and identification of terminal alpha-linked galactose.
Sheeley DM; Merrill BM; Taylor LC
Anal Biochem; 1997 Apr; 247(1):102-10. PubMed ID: 9126378
[TBL] [Abstract][Full Text] [Related]
3. Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material.
Crowe JS; Hall VS; Smith MA; Cooper HJ; Tite JP
Clin Exp Immunol; 1992 Jan; 87(1):105-10. PubMed ID: 1339322
[TBL] [Abstract][Full Text] [Related]
4. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
[TBL] [Abstract][Full Text] [Related]
5. Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions.
Lifely MR; Hale C; Boyce S; Keen MJ; Phillips J
Glycobiology; 1995 Dec; 5(8):813-22. PubMed ID: 8720080
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic mapping of the oligosaccharides released from the humanised immunoglobulin, CAMPATH 1H.
Lines AC
J Pharm Biomed Anal; 1996 Mar; 14(5):601-8. PubMed ID: 8738190
[TBL] [Abstract][Full Text] [Related]
7. Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants.
Dashivets T; Thomann M; Rueger P; Knaupp A; Buchner J; Schlothauer T
PLoS One; 2015; 10(12):e0143520. PubMed ID: 26657484
[TBL] [Abstract][Full Text] [Related]
8. 1.9 A structure of the therapeutic antibody CAMPATH-1H fab in complex with a synthetic peptide antigen.
James LC; Hale G; Waldmann H; Bloomer AC
J Mol Biol; 1999 Jun; 289(2):293-301. PubMed ID: 10366506
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of a rat anti-CD52 (CAMPATH-1) therapeutic antibody Fab fragment and its humanized counterpart.
Cheetham GM; Hale G; Waldmann H; Bloomer AC
J Mol Biol; 1998 Nov; 284(1):85-99. PubMed ID: 9811544
[TBL] [Abstract][Full Text] [Related]
10. Engineering multiple-domain forms of the therapeutic antibody CAMPATH-1H: effects on complement lysis.
Greenwood J; Gorman SD; Routledge EG; Lloyd IS; Waldmann H
Ther Immunol; 1994 Oct; 1(5):247-55. PubMed ID: 7584499
[TBL] [Abstract][Full Text] [Related]
11. Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells.
Wright A; Morrison SL
J Immunol; 1998 Apr; 160(7):3393-402. PubMed ID: 9531299
[TBL] [Abstract][Full Text] [Related]
12. Structure determination of the intact major sialylated oligosaccharide chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells.
Watson E; Bhide A; van Halbeek H
Glycobiology; 1994 Apr; 4(2):227-37. PubMed ID: 8054720
[TBL] [Abstract][Full Text] [Related]
13. Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a gamma 4 variant of Campath-1H.
Hutchins JT; Kull FC; Bynum J; Knick VC; Thurmond LM; Ray P
Proc Natl Acad Sci U S A; 1995 Dec; 92(26):11980-4. PubMed ID: 8618827
[TBL] [Abstract][Full Text] [Related]
14. Human serotonectin: a blood glycoprotein that binds serotonin. Chemical and physiological characterization.
Mella A; Peing LK; Hadassah T
Biochim Biophys Acta; 1986 Feb; 880(2-3):139-46. PubMed ID: 3942785
[TBL] [Abstract][Full Text] [Related]
15. Lectin analysis of human immunoglobulin G N-glycan sialylation.
Dalziel M; McFarlane I; Axford JS
Glycoconj J; 1999 Dec; 16(12):801-7. PubMed ID: 11133020
[TBL] [Abstract][Full Text] [Related]
16. A systematic approach to the validation of process control parameters for monoclonal antibody production in fed-batch culture of a murine myeloma.
Moran EB; McGowan ST; McGuire JM; Frankland JE; Oyebade IA; Waller W; Archer LC; Morris LO; Pandya J; Nathan SR; Smith L; Cadette ML; Michalowski JT
Biotechnol Bioeng; 2000 Aug; 69(3):242-55. PubMed ID: 10861404
[TBL] [Abstract][Full Text] [Related]
17. Effective therapy for a murine model of adult T-cell leukemia with the humanized anti-CD52 monoclonal antibody, Campath-1H.
Zhang Z; Zhang M; Goldman CK; Ravetch JV; Waldmann TA
Cancer Res; 2003 Oct; 63(19):6453-7. PubMed ID: 14559836
[TBL] [Abstract][Full Text] [Related]
18. A chromatographic approach for elevating the antibody-dependent cellular cytotoxicity of antibody composites.
Tojo S; Okazaki A; Wakitani M; Shinkawa T; Uchida K; Suzawa T
Biol Pharm Bull; 2009 Sep; 32(9):1604-8. PubMed ID: 19721240
[TBL] [Abstract][Full Text] [Related]
19. Analysis of N-acetyl-4-O-acetylneuraminic-acid-containing N-linked carbohydrate chains released by peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase F. Application to the structure determination of the carbohydrate chains of equine fibrinogen.
Damm JB; Voshol H; Hård K; Kamerling JP; Vliegenthart JF
Eur J Biochem; 1989 Mar; 180(1):101-10. PubMed ID: 2707257
[TBL] [Abstract][Full Text] [Related]
20. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1.
Wright A; Morrison SL
J Exp Med; 1994 Sep; 180(3):1087-96. PubMed ID: 8064227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
